SZLS.TO
StageZero Life Sciences Ltd
Price:  
0.04 
CAD
Volume:  
8,405.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SZLS.TO WACC - Weighted Average Cost of Capital

The WACC of StageZero Life Sciences Ltd (SZLS.TO) is 6.3%.

The Cost of Equity of StageZero Life Sciences Ltd (SZLS.TO) is 7.85%.
The Cost of Debt of StageZero Life Sciences Ltd (SZLS.TO) is 4.25%.

Range Selected
Cost of equity 6.20% - 9.50% 7.85%
Tax rate 25.90% - 26.50% 26.20%
Cost of debt 4.00% - 4.50% 4.25%
WACC 5.1% - 7.4% 6.3%
WACC

SZLS.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.6 0.88
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.20% 9.50%
Tax rate 25.90% 26.50%
Debt/Equity ratio 0.52 0.52
Cost of debt 4.00% 4.50%
After-tax WACC 5.1% 7.4%
Selected WACC 6.3%